Leonard Braden Michael sold ACRS
April 23, 2026 · Form 4 insider transaction
Leonard Braden Michael sold 300,000 shares of Aclaris Therapeutics, Inc. at $4.53 per share, a transaction worth $1.36M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.